---
document_datetime: 2025-09-29 09:37:31
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/yuflyma-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: yuflyma-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 5.0587508
conversion_datetime: 2025-12-29 21:12:29.46885
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Yuflyma

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency' s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessmenthistory'section.Forthe completeproduct lifecycleprocedures,you mayneedtoalsorefertoEPAR-Proceduralsteps taken andscientific information after authorisation (archive).

| Applicationnumber   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision IssuedÂ²/ amendedon   | Product Information affected3   | Summary   |
|---------------------|----------------------------------------|-------------------------------------|------------------------------------------|---------------------------------|-----------|
| Variation type IA / | This was an application for a group of | 25/09/2025                          |                                          | Annex II and                    |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000300812                     | variations. A.ADMINISTRATIVECHANGES-A.7 Deletion of manufacturingsitesfor an active substance,intermediate orfinished product, packaging site, manufacturer responsible for batch release, site where batch control takes place,orsupplierof astartingmaterial, reagent or excipient (when mentioned in the dossier)*- Accepted A.ADMINISTRATIVE CHANGES-A.7 Deletionofmanufacturingsitesforanactive substance,intermediateorfinishedproduct, packaging site, manufacturer responsible for batchrelease,sitewherebatchcontroltakes place, or supplier of a starting material, reagent or excipient (when mentioned in the   |            |            | PL          |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-------------|
| Variation type IB / EMA/VR/0000255330 | B.II.f.1.b Extension of the shelf life of the finished product-B.1I.f.1.b.5Extension of theshelf-lifeofabiological/immunological medicinal product in accordancewith an approved stability protocol-Accepted                                                                                                                                                                                                                                                                                                                                                                                                                | 27/03/2025 | 02/09/2025 | SmPC and PL |
| Variation type IB / EMA/VR/0000253120 | This was an application for a group of variations. B.II.b.1 Replacement or addition of a manufacturingsiteforpartor all ofthe                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | 20/03/2025 | N/A        |             |

<div style=\"page-break-after: always\"></div>

| manufacturing process of the finished product - B.II.b.1.z Other changes - Accepted B.II.b.2 Change to importer,batch release arrangements and quality control testing of the finished product-B.1I.b.2.a Replacement or addition of a site where batch control/testing takes place - Accepted   |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|